Drug Details
General Information of the Drug (ID: DR5892) | ||||
---|---|---|---|---|
Name |
GSK2041706
|
|||
Synonyms |
GPR119 agonist; 1037779-47-7; SCHEMBL2370813; ZINC95929383; 5-[4-[(2R)-4-(3-fluoro-4-methylsulfonylphenoxy)butan-2-yl]piperidin-1-yl]-3-propan-2-yl-1,2,4-oxadiazole
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Type 2 diabetes mellitus [ICD-11: 5A11] | Investigative | [1] | |
Structure |
![]() |
Click to Download Mol2D MOL |
||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
C21H30FN3O4S
|
|||
PubChem CID | ||||
Canonical SMILES |
CC(C)C1=NOC(=N1)N2CCC(CC2)C(C)CCOC3=CC(=C(C=C3)S(=O)(=O)C)F
|
|||
InChI |
1S/C21H30FN3O4S/c1-14(2)20-23-21(29-24-20)25-10-7-16(8-11-25)15(3)9-12-28-17-5-6-19(18(22)13-17)30(4,26)27/h5-6,13-16H,7-12H2,1-4H3/t15-/m1/s1
|
|||
InChIKey |
AJJISMLYIMQAKP-OAHLLOKOSA-N
|
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Metformin | Galega officinalis | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [1] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vivo Model | Diet-induced obese (DIO) mouse models were used in this study. | |||||
Experimental
Result(s) |
The combination of GSK2041706 with metformin caused greater reductions in cumulative food intake (22.2% at 30 mg/kg and 37.5% at 100 mg/kg) and higher fed plasma glucagon-like peptide 1 and peptide tyrosine tyrosine levels and decreased plasma insulin and glucose-dependent insulinotropic polypeptide levels compared with their monotherapy groups. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Programmed cell death protein 5 (PDCD5) | Molecule Info | [2] |
